𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DOPA and amino acid levels in plasma and cerebrospinal fluid of patients with parkinson's disease before and during treatment with L-dOPA

✍ Scribed by T.A. Hare; B.L. Beasley; R.A. Chambers; D.H. Boehme; W.H. Vogel

Book ID
115820107
Publisher
Elsevier Science
Year
1973
Tongue
English
Weight
579 KB
Volume
45
Category
Article
ISSN
0009-8981

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Dementia and treatment with L-dopa in Pa
Dementia and treatment with L-dopa in Parkinson's disease
✍ M. Hietanen; Dr. H. TerΓ€vΓ€inen πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 536 KB

We compared the neuropsychological performance of patients with Parkinson's disease who were young at onset of the disease (mean age, 41.4 years) and had received prolonged L-dopa treatment (mean, 52.1 months) with nontreated patients of the same age. A similar comparison was made for patients who w